-
公开(公告)号:EP4046499B1
公开(公告)日:2024-11-13
申请号:EP20877757.3
申请日:2020-03-19
发明人: FUJII Kengo , MIYAUCHI Hirofumi
-
公开(公告)号:EP4456880A1
公开(公告)日:2024-11-06
申请号:EP21851701.9
申请日:2021-12-29
IPC分类号: A61K9/16 , A61K9/00 , A61K9/10 , A61K31/445 , A61P37/08
-
公开(公告)号:EP3878449B1
公开(公告)日:2024-10-30
申请号:EP21151865.9
申请日:2015-09-17
IPC分类号: A61K31/427 , A61K31/455 , A61K31/122 , A61K31/425 , A61K9/08 , A61K9/10 , A61P27/02 , A61P27/06 , A61K47/26 , A61K47/32 , A61K47/38
-
公开(公告)号:EP4442269A1
公开(公告)日:2024-10-09
申请号:EP22900342.1
申请日:2022-11-23
发明人: HUANG, Jingfeng , LIU, Yanan , DU, Tieliang
摘要: A use of alanyl-glutamine in preparation for a drug for treating, relieving or alleviating ocular surface diseases and/or conditions of non-dry eyes. A use of alanyl-glutamine in preparation for a drug for relieving or alleviating visual fatigue. A use of alanyl-glutamine in preparation for a beauty product and health-care product for relieving or alleviating asthenopia.
-
公开(公告)号:EP4433026A1
公开(公告)日:2024-09-25
申请号:EP22818326.5
申请日:2022-11-16
IPC分类号: A61K9/10 , A61K31/505 , A61K38/47 , A61K9/50 , A61K9/14
CPC分类号: A61K9/145 , A61K31/505
-
公开(公告)号:EP4429639A1
公开(公告)日:2024-09-18
申请号:EP22839012.6
申请日:2022-11-10
发明人: OSBORNE, David W. , TOFIG, Babak N.
CPC分类号: A61K9/0014 , A61K9/10 , A61K47/38 , A61K47/20
-
公开(公告)号:EP4429636A1
公开(公告)日:2024-09-18
申请号:EP22826543.5
申请日:2022-11-08
申请人: Crititech, Inc.
发明人: SITTENAUER, Jacob , ABARCA, Aranza Barreda , CLARK, Shelby , FARTHING, Joseph , WILLIAMS, Mark , DIZEREGA, Gere S. , BALTEZOR, Michael
CPC分类号: A61K9/1688 , A61K9/10 , A61K9/0078 , A61K9/0019 , A61K31/55
-
公开(公告)号:EP4422595A1
公开(公告)日:2024-09-04
申请号:EP22809733.3
申请日:2022-10-25
申请人: O11-biomedical GmbH
CPC分类号: A61K9/1635 , A61K9/10 , A61K9/0019 , A61P43/00
-
公开(公告)号:EP4349327A3
公开(公告)日:2024-07-24
申请号:EP23216625.6
申请日:2019-08-28
发明人: NI, Jinsong , DINH, Van , TIEN, Walter
IPC分类号: A61K9/107 , A61K9/10 , A61P27/02 , A61K9/00 , A61K31/4439 , A61K31/496 , A61K31/506 , A61K31/517 , A61K31/519 , A61K31/5377 , A61K47/26 , A61K47/44 , A61K47/40
CPC分类号: A61K9/107 , A61P27/02 , A61K9/0048 , A61K47/44 , A61K47/40 , A61K47/26 , A61K31/4439 , A61K31/517 , A61K31/496 , A61K31/506 , A61K31/519 , A61K31/5377
摘要: Compositions comprising a therapeutically effective amount of a multikinase inhibitor, such as nintedanib or axitinib or pazopanib, are provided, wherein the composition is an emulsion, such as a nanoemulsion, with lipophilic carrier (e.g., castor oil), a polyoxyl oil (e.g., polyolyl-35 castor oil), optionally with a surfactant (e.g., polysorbate 80), optionally with a cyclic oligosaccharide, such as a cyclodextrin (e.g., 2-hydroxypropyl-beta-cyclodextrin), as a solubilizer. Methods for treating ocular conditions with the compositions are also provided.
-
10.
公开(公告)号:EP4395746A1
公开(公告)日:2024-07-10
申请号:EP22865833.2
申请日:2022-09-02
发明人: AGRAHARI, Vivek , DONCEL, Gustavo Fabian , NGUYEN, Thanh Duc , LIN, Feng , TRAN, Khanh , SINGH, Onkar Nath
CPC分类号: A61K9/127 , A61K39/39 , A61K39/12 , A61P31/14 , C12N2770/2003420130101 , A61K2039/5320130101 , A61K2039/54520130101 , C07K14/005 , C12N2770/2002220130101 , C12N15/67 , A61K9/0019 , A61K9/5123 , A61K47/6455 , A61K47/543 , A61K47/6929 , A61K47/6911
-
-
-
-
-
-
-
-
-